(Q51982061)

English

The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease: a Markov model.

scientific article published in July 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10463520

The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease: a Markov model. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10463520

cost-effectiveness analysis

1 reference

based on heuristic

inferred from title

Alzheimer's disease

1 reference

based on heuristic

inferred from title

0 references

2

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10463520

3

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10463520

5

object named as

Winblad B

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10463520

author name string

Jönsson L

1

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10463520

Jönsson B

4

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10463520

publication date

1 July 1999

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10463520

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10463520

21

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10463520

7

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10463520

1230-1240

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10463520

The US economic and social costs of Alzheimer's disease revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980025-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The economic impact of the tacrine in the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980025-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic impact of introducing propentofylline for the treatment of dementia in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980025-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980025-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(00)80025-9

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10463520

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/10463520

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51982061&oldid=1543844573"